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Summary 
 
Intercellular communication is achieved at specialized regions of the plasma membrane by 
gap junctions. Gap junctions are transmembrane channels allowing direct contacts between 
the cytoplasms of neighboring cells. Each cell participates with one hemichannel, or 
connexon, made of six protein subunits named connexins. Thanks to these junctions, cells 
potentially share a pool of small molecules and metabolites, such as nucleotides, amino acids 
and second messengers.  
In an ischemic (i.e. non-perfused) territory of the brain, irreversible damage progresses over 
time from the centre of the most severe flow reduction to the periphery with less disturbed 
perfusion. Functionally impaired tissue can survive and recover if sufficient reperfusion is re-
established within a limited time period, which depends on various factors and mechanisms 
modulating the signaling pathways leading to cell death. 
Observations were made indicating the presence of electrical coupling between neurons which 
resist better to an ischemic insult. This electrical coupling is likely to be mediated by 
Connexin36 (Cx36), a neuron specific connexin isoform. It was demonstrated in the past that 
global ischemia induces a selective upregulation of Cx36 expression in regions with neurons 
that survive the insult whereas others undergo apoptosis and die. These observations raise the 
possibility that the neuronal gap junction Cx36 might play a role in the destiny of neurons 
after cerebral ischemia. 
The aim of this work was to characterize the regulation of Connexin36 in a mouse model of 
transient focal cerebral ischemia by immunofluorescence and Western blot analysis. Our 
immunofluorescence results suggest a specific increase in Cx36 in the penumbral region of 
the ischemic hemisphere. 
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1. INTRODUCTION 
1.1 Connexin, connexon, gap junction 
Gap junctions are specialized membrane regions composed of aggregates of transmembrane 
channels that directly connect the cytoplasm of adjacent coupled cells. These intercellular 
channels are present in almost all cell types of vertebrate organisms. The passage of ions and 
small molecules with a molecular weight smaller than 1,2 kDa through the gap junction-
channels results in metabolic and electrical coupling of cells (Condorelli, Belluardo et al. 
2000). As a result, gap-junctions synchronize activity of coupled cells and are thought to play 
an important role in intercellular signalling in brain development, morphogenesis and pattern 
formation (Goodenough and Paul 2009). The gap junction comprises two apposed hexameric 
structures called connexons (or hemichannels), one contributed by each cell. These connexons 
eventually contact each other to bridge a gap of approximately 3nm between the two cell 
membranes. Each connexon is composed of six connexin subunits surrounding a central pore 
(Figure1).  
 
 
 
 
 
 
 
 
 
Connexins are encoded by a gene family of at least 20 structurally related members in 
mammals. Although connexins share sequence similarity and a common membrane topology, 
  
 
Figure 1) Connexin, connexon, gap junction  
(adapted from Allagnat, Thesis, 2005; Alonso, Thesis 2011) 
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they assemble and form channels that differ in gating and permeability properties as well as 
temporal and spatial patterns of expression (Oguro, Jover et al. 2001). 
In the nervous system, gap junction-mediated communication is the most common form of 
electronic coupling between neurons. Interneuronal gap junctions provide the structural basis 
for the so-called “electrical synapses”, where multiple gap junctions assemble to form an 
array (“plaque”) and couple mechanically and electrically two adjacent neurons thus 
providing a conductive link for exchanging signals (Condorelli, Belluardo et al. 2000). 
1.2. Different cell types in the brain 
The brain is composed of neurons and a special connective tissue called glial tissue (Figure 
2). Although neurons vary in structure, functional interconnections and biochemical 
properties, they share some fundamental aspects: a neuron is an electrically excitable cell 
transmitting information by electrical and chemical signalling. Neurons transmit information 
through cytoplasmic prolongations, called axons, building neuronal circuits leading to a 
network which gives rise to the possibility of integrating, processing and transmitting 
information. Neurons are, compared to other cell types, relatively unable to regenerate. This 
means that focal neuronal loss can result in permanent symptomatic neurologic deficits 
((Kumar and Robbins 2007).  
Glial cells (astrocytes, oligodendrocytes and microglia) provide a support function for 
neurons and their cellular processes. They also have a primary role in repair, fluid balance and 
energy metabolism. 
Astrocytes (so called because of their stellate morphology) have processes that are directed 
toward capillaries and neurons. Important normal functions include structural support, 
contributions to the blood-brain barrier and action as metabolic buffers or detoxifiers. They 
are the principal cells responsible for repair and scar formation in the brain. ((Kumar and 
Robbins 2007). Astrocytes contain the intermediate filament glial fibrillary acidic protein 
(GFAP) which can be used as a cell-type specific marker for differentiated astrocytes. When 
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there is a brain lesion (such as after an ischemic insult), astrocytes become reactive, creating a 
physical barrier between healthy and damaged tissue which can be identified by the study of 
anti-GFAP immunofluorescence (Benakis, Bonny et al. 2010). 
Oligodendrocytes are the cells producing the myelin sheats which surround neuronal axons, 
providing acceleration of the conduction process of information. Microglia are mobile, acting 
as cells of the immune system in the brain, they phagocyte damaged tissue, microorganisms, 
as well as antibody-antigen complexes. (Waxman 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3. Connexins in the brain 
Three gap junction-proteins are expressed abundantly in mammalian brain (but with differing 
cellular specificity): Connexin 32 (Cx32), Connexin 36 (Cx36) and Connexin 43 (Cx43). 
Whereas Cx43 is the most abundant connexin expressed by astrocytes, Cx32 is expressed 
predominantly in oligodendrocytes. Cx36 protein expression is neuron specific (Condorelli, 
Trovato-Salinaro et al. 2003; Sohl, Maxeiner et al. 2005). Characterizing temporal, spatial and 
 
Figure 2) Different cell types in the brain 
http://www.nature.com/nature/journal/v457/n7230/fig_tab/457675a_F1.html 
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cellular differences in connexin expression is crucial to better understand their role in the 
brain in normal and pathophysiological conditions. 
1.4. Cerebral ischemia 
Cerebral ischemia (i.e. non-perfusion of the brain) is most often caused by a cerebrovascular 
accident which denotes any abnormality of the brain caused by a pathologic process involving 
blood vessels. The three basic mechanisms are thrombotic occlusion of vessels, embolic 
occlusion of vessels and vascular rupture (Figure 3). The first two share many characteristics, 
because their effect on the brain is the same: Loss of oxygen and metabolic substrates finally 
resulting in brain infarction. Thrombosis and embolism cause ischemic injury or infarction of 
specific regions of the brain, depending on the vessel involved. A similar pattern of injury 
occurs diffusely when there is complete loss of brain perfusion. Rupture of vessels leads to 
direct tissue damage as well as secondary ischemic injury. A “stroke” is the clinical 
designation that applies to all these conditions, particularly when symptoms begin acutely. 
The stroke or cerebrovascular accident remains a major health problem and is a leading cause 
of death and disability (Kumar and Robbins 2007).  
 
 
Figure 3) Mechanisms leading to a cerebrovascular accident 
http://www.lookfordiagnosis.com/images.php?term=Cerebrovascular+Accident&lang=1&from=8 
 
 8 
Cerebral ischemia induces neuronal damage in the territory of the non-perfused artery. The 
rapid decrease of oxygen and glucose in the ischemic region can cause profound cellular 
dysregulations within minutes. The fundamental biochemical abnormality in hypoxic neurons 
that leads to cell injury is reduced intracellular generation of adenosinetriphosphate (ATP), as 
a consequence of absent supply of O2. Loss of ATP leads to the failure of many energy-
dependent cellular systems, including ion pumps (leading to swelling and influx of Ca++), 
depletion of glycogen stores (with accumulation of lactic acid, thus lowering the intracellular 
pH) and reduction of protein synthesis (Kumar and Robbins 2007). 
 In early stages or mild forms of injury, the functional and morphologic cell changes are 
reversible if the damaging stimulus is removed. With continuing damage, the injury becomes 
irreversible, at which the cell cannot recover and dies.  
In an ischemic territory of the brain, irreversible damage progresses over time from the centre 
of the most severe flow reduction to the periphery with less disturbed perfusion. The zone 
between damaged and the functional brain tissue is referred to as the penumbra. The concept 
of penumbra during focal cerebral ischemia refers to the regions of brain tissue where blood 
flow is sufficiently reduced to cause hypoxia arresting cell function, but not so complete as to 
cause irreversible failure of energy metabolism resulting in cell death. As tissue tolerance to 
ischemic damage is dependent on residual blood flow and duration of flow disturbance, 
ischemic penumbra is a dynamic process. It exists for a short time even in the center of an 
ischemic region, from where cell death propagates to the neighboring tissue over time 
(Paciaroni, Caso et al. 2009). 
There are two types of cell death, necrosis and apoptosis, which differ in their morphology, 
mechanisms and roles in cerebral ischemia. The term necrosis refers to a series of changes 
that accompany cell death in lethally injured cells which are unable to maintain membrane 
integrity. When damage to membranes is severe, enzymes leak out of lysosomes, enter the 
cytoplasm, and digest the cell, resulting in necrosis. Cellular contents also leak out and elicit a 
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host reaction (inflammation). When a cell is deprived of growth factors or the cell’s DNA or 
proteins are damaged beyond repair, the cell kills itself by another type of death, called 
apoptosis. Apoptosis is an active, energy-dependent pathway of cell death that is induced by a 
tightly regulated suicide program in which cells destined to die activate enzymes degrading 
DNA as well as nuclear and cytoplasmic proteins. The fundamental event in apoptosis is the 
activation (=cleavage of zymogens into active forms) of enzymes called caspases (so named 
because they are cysteine proteases that cleave proteins after aspartic residues). The activation 
of caspases depends on a finely tuned balance between pro- and anti-apoptotic signals and 
intracellular proteins (Kumar and Robbins 2007). 
In a cerebrovascular accident, the first wave of neuronal death is mainly by necrosis in the 
immediate vicinity of the center of the ischemic region, while apoptosis is the main form of 
cell death at later time points in the progressing penumbra (Nakase, Fushiki et al. 2003; 
Talhouk, Zeinieh et al. 2008). 
The penumbra concept furthermore suggests that functionally impaired tissue can survive and 
recover if sufficient reperfusion is re-established within a limited time period, which depends 
on various factors and mechanisms modulating the signaling pathways leading to apoptosis. 
One of the challenges in understanding the dynamics of cell survival during reperfusion of the 
penumbral region is that it relies on complex interplay between the different cell-types present 
in the central nervous system, especially since they exhibit different resistances to an ischemic 
insult such as a cerebrovascular accident (Kumar and Robbins 2007). At any given survival 
time, one region may include subpopulations of dead, damaged and regenerating cells that 
influence each other in ways that still need to be elucidated (Talhouk, Zeinieh et al. 2008). 
As neurons have a high demand on energy, they are especially sensitive to O2 and glucose 
deprivation occurring during ischemia. Astrocytes, which are more resistant than neurons, are 
initially activated in the lesion, produce various cytokines, interact with inflammatory cells 
and accumulate glycogen for energy supply under ischemic conditions (Mehta, Manhas et al. 
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2007; Tuttolomondo, Di Raimondo et al. 2008; Xia, Han et al. 2010). They maintain the 
extracellular glutamate concentration, thereby reducing metabolic stress to neurons associated 
with activity and reduce cytotoxic reactive oxygen species accumulation (Kunz, Park et al. 
2007). Therefore, astrocytes are considered to protect neurons from ischemic insults.  
1.5. Gap junctions in cerebral ischemia 
The intercellular communication and regulatory mechanisms taking place in an ischemic brain 
region described above are thought to be, at least partially, mediated via gap junctional 
intercellular signalling. In vitro blocking of gap junctions in neuron-astrocyte co-cultures 
leads to a decrease of these protective mechanisms (Ozog, Siushansian et al. 2002). On the 
other hand, there is evidence supporting a role for interastrocytic gap junctions in the spread 
of secondary injury associated with focal ischemia: gap junctions between dying glial cells 
such as astrocytes can kill resistant neighboring glial cells via glial “fratricide” (bystander 
death) and thereby propagate and spatially amplify injury (Lin, Weigel et al. 1998). Under 
ischemic conditions, the pro- or antiapoptotic role of astrocytic gap junctions is still 
controversial in literature (Nakase and Naus 2004; Talhouk, Zeinieh et al. 2008).  
In an animal model, transient cerebral ischemia induces selective, delayed neuronal death. 
Some neurons in the brain are resistant to ischemic insults that kill others and survive (Oguro, 
Jover et al. 2001). The molecular mechanisms underlying the cell-specific pattern of 
ischemia-induced neuronal death are not well understood. 
There is morphological evidence indicating the presence of electrical coupling between 
neurons which resist better to an ischemic insult (Oguro, Jover et al. 2001). Observations were 
made indicating that this electrical coupling is likely to be mediated by Cx36, which is highly 
expressed in these neurons (Condorelli, Belluardo et al. 2000). Transient global ischemia 
induces a selective upregulation of Cx36 expression in neurons that survive the insult whereas 
others undergo apoptosis and die (Oguro, Jover et al. 2001). These observations raise the 
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possibility that Cx36 gap junctions might play a role in the destiny of neurons after transient 
ischemia. 
Gap junctions linking these neurons are thought to synchronize and reinforce inhibitory 
synaptic transmission supporting a role for gap junctions in promotion of resistance and 
survival of selected neuronal populations to ischemia-induced damage. The inhibitory signal 
is thought to reduce vulnerability because of reduced metabolic stress associated with less 
neuronal activity (Oguro, Jover et al. 2001). 
The present work was undertaken to examine the expression of Cx36 in neurons in the 
penumbral region of a focal ischemic lesion in the mouse brain. The lesion was induced by 
selective transient middle cerebral artery occlusion as stroke model.
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2. MATERIAL AND METHODS 
2.1. Animals 
Adult wild type ICR mice (20-35g), 4-5 weeks old were used by the group of Prof. Lorenz 
Hirt, Laboratory of Neurology, CHUV, Lausanne. 
2.2. Transient middle cerebral artery occlusion (MCAo) 
The mouse model of the MCAo was performed by Dr. Wilfredo Puentes from the group of 
Prof. Lorenz Hirt, Laboratory of Neurology, CHUV, Lausanne as previously described 
(Benakis, Bonny et al. 2010). Mice where anesthetized and maintained with 1-3% isoflurane 
in 70% N2O and 30% O2 using a face mask. Body temperature was maintained at 37± 0,5° C  
throughout surgery (FHC Inc., Bowdoinham, ME, US). Regional cerebral blood flow was 
continuously recorded by laser Doppler flowmetry (LDF, Periflux 5000, Perimed, Sweden) 
during a period covering the induction of ischemia until 10min after the end of ischemia. 
Transient focal cerebral ischemia was induced by the following steps: ligature of left proximal 
arteria carotis communis near the aortic arch and ligature of left proximal arteria carotis 
externa, temporary clip on left distal arteria carotis interna and incision of the now non-
perfused left arteria carotis communis to introduce a silicone coated nylon monofilament 
(diameter: 0,17mm, Docol Co., Redlands, CA, US) through the left arteria carotis communis. 
Ligature and fixation of the nylon monofilament on proximal left arteria carotis interna. 
Withdrawal of monofilament after 30min to allow reperfusion. Mice were given 0,025mg/kg 
of buprenorphine subcutaneously for post-surgery analgesia and were housed in an incubator 
at 31° C during 24h for recovery. 
2.3. Tissue preparation 
Mice were profoundly anesthetized with intraperitoneal xylazine injection, killed by cervical 
dislocation and transcardially perfused with phosphate-buffered saline (PBS), pH 7,4 injected 
into the left ventriculum. Simultaneously, the vena cava inferior was dissected allowing the 
blood and PBS to exit the vascular system. Mice where then decapitated and the brain 
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extirpated. Isolated brains were positioned slightly above liquid nitrogen in a recipient so that 
it can be frozen by the vapour of the nitrogen. Sections of the frozen specimen were cut with a 
cryostat (Cryostat CM3050 S, Leica Microsystems, Wetzlar, Germany) at -10° C and a 
chamber temperature of -15° C. Serial coronal 10µm thick, 700µm distant frozen sections 
were cut for immunolabelling. 25µm and 50µm thick coronal slices between the 10µm slices 
were cut for cresyl violet staining and Western blot analysis respectively. Brain sections were 
mounted on glass plates (SuperFrost Ultra Plus, Menzel, Braunschweig, Germany) and kept at 
-80° C. 
2.4. Cresyl violet staining  
For a macroscopic analysis, neuronal damage was assessed by histological examination of the 
damaged as well as the control tissue of brain sections at the level of the lesion, 25µm thick 
slices were stained in cresyl violet by the group of Prof. Lorenz Hirt, Laboratory of 
Neurology, CHUV, Lausanne.  
2.5. Immunofluorescence analysis 
For qualitative evaluation as well as anatomical localization of apoptosis in the ischemic 
region, we used rabbit anti-cleaved caspase 3 antibodies (Cell Signaling Technology, 
Danvers, MA, US) on 10µm thick coronal sections of the brain. For the cleaved caspase 3 
marking, the cryoconservated sections were rehydrated in phosphate-buffered saline (PBS), 
fixed during 10min with 4% Paraformaldehyd in PBS and permeabilized in phosphate-
buffered saline-bovine serum antigen (PBS-BSA) 1,5% Triton 0,1% during 1 hour at room 
temperature. Then, sections were incubated overnight at 4° C with anti-cleaved caspase 3 
antibodies (1:500) in PBS-BSA 1%.  The primary antibodies were visualized using goat anti-
rabbit Alexa Fluor 488 (1:1000, Invitrogen, Carlsbad, CA, US) in PBS-BSA 1%. 
For the anti-Cx36, anti-Cx43 and anti-GFAP immunofluorescence studies, 10µm thick 
coronal sections of the brain were rehydrated in PBS followed by permeabilization in PBS-
BSA 1,5% Triton 0,1% during 1 hour at room temperature. Then, sections were incubated 
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overnight at 4° C alone or in combinations of the following primary antibodies diluted in 
PBS-BSA 1%: mouse anti-GFAP (1:250, Millipore, Billerica, MA, US), rabbit anti-Cx43 
(1:1000; Cell Signalling Technology, Danvers, MA, US), rabbit anti-Cx36 (1:50; Invitrogen, 
Carlsbad, CA, US). 
Antigens were visualized with the appropriate fluorochrome-conjugated secondary antibodies 
diluted in PBS-BSA 1%: goat anti-mouse Alexa Fluor 594 (1:400, Invitrogen, Carlsbad, CA, 
US), goat anti-rabbit Alexa Fluor 488 (1:1000, Invitrogen, Carlsbad, CA, US) respectively. 
Sections were counterstained with DAPI and mounted in Mounting Medium (Vectashield, 
Vector Laboratories, Burlingame, CA, US) diluted 1:3 in 50% glycerol. Images were acquired 
with a Leica microscope (Leica Microsystems, Wetzlar, Germany). 
2.7. Western blot analysis 
For quantification of protein abundance in the lesion and the surrounding ischemic penumbra, 
50µm coronal slices were cut on a cryostat (Cryostat CM3050 S, Leica Microsystems, 
Wetzlar, Germany). To minimize “dilution” of the ischemic tissue of interest, only slices with 
a macroscopically visible lesion were used for Western blot analysis. The slices were cut in 
half along the fissura longitudinalis cerebri and around the macroscopically visible lesion to 
reduce the amount of non ischemic tissue in the sample used for analysis of the ischemic 
region. Tissue samples were homogenized by sonication in sodium dodecylsulfate (SDS) lysis 
buffer solution (62.5mM Tris-EDTA, pH 6.8, 5% SDS). Protein concentrations of the samples 
were measured using the DC protein assay (Bio-Rad, Hercules, CA, US). Samples were 
diluted in SDS lysis buffer to achieve the same final protein concentration, proteins were 
denaturated by loading buffer and 5min heating in a thermoblock at 98° C.  
Samples containing the same final protein amount were loaded onto 12% polyacrylamide gels 
and subjected to gel electrophoresis.  
Protein bands were transferred to immobilon PVDF membranes (Millipore, Billerica, MA, 
US). Membranes were blocked during 1h at room temperature in blocking buffer (TBS-
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Tween 0.1%-skim milk 5%). Then, membranes were incubated with a primary antibody (anti-
Cx36 1:100, anti-Cx43 1:100) in TBST-BSA 5% overnight in a 4° C cold-chamber. After 
3x10min TBST washes, the membranes were incubated in goat anti-rabbit antibodies coupled 
to the horseradish peroxidase (HRP) diluted in blocking buffer (1:10’000, Millipore, Billerica, 
MA, US) during 1h at room temperature. After reaction and 3x10min consecutive TBST 
washes, membranes were treated with enhanced chemiluminescence reagents (HRP 
Immobilon substrate, Millipore, Billerica, MA, US).) and exposed to Kodak films (Kodak, 
Rochester, NY, US). 
 16 
3. RESULTS 
3.1. Transient middle cerebral artery occlusion induces a visible lesion on cresyl violet 
stained mouse brain slices 
To examine ischemia-induced alterations in connexin expression in the mouse brain, mice 
were subjected to transient focal cerebral ischemia by selective transient middle cerebral 
artery occlusion (MCAo) for 30 min and housed during 24h before sacrifice. To assess 
qualitatively brain damage in the territory of the occluded artery after MCAo, brain sections 
were subjected to macroscopic histological analysis (Figure 4). At 24h after a 30min MCAo, 
almost all mice showed a histologically visible lesion in cresyl violet staining which presented 
as a region with less intense staining in the left hemisphere (Figure 4B and C). The left 
hemisphere, which was subjected to 30min of MCAo, showed either one of the following two 
lesion patterns: A smaller, striatal lesion which affects only the striatum and seems to be 
limited by the corpus callosum (Figure 4B) or, a bigger, corticostriatal lesion, extending from 
the striatum into the left cortex (Figure 4C). 
 
 
 
 
 
 
 
3.2. Cleaved caspase 3 immunofluorescence shows a visible frontier between labelling-
positive and negative cells in the hemisphere with focal cerebral ischemia 
For a more detailed evaluation of the damaged hemisphere, we used cleaved caspase 3 
immunofluorescence which allowed us to confirm or exclude the presence of apoptosis in the 
ischemic and the adjacent normal brain parenchyma (Figure 5). We found that the localisation 
A            B         C 
   
Figure 4) Cresyl Violet staining on mice brain 24h after 30min MCAo: A: sham, B: striatal lesion, 
C: corticostriatal lesion. Squares indicate the determined regions of interest. 
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of cleaved caspase 3 labelling was identical to the lesion observed on the cresyl violet stained 
slices. We concluded that the external limit of the area containing cleaved caspase 3 positive 
cells should be the region of interest to be observed with the consecutive immunofluorescence 
methods. 
 
3.3. Focal cerebral ischemia modulates Connexin36 levels 
To examine ischemia-induced alterations in Cx36 expression, consecutive slices from the 
same mice brains used for cresyl violet staining and anti-cleaved caspase 3 were used. 
Immunofluorescence studies were performed using specific antibodies against Cx36 in order 
to qualitatively compare the membraneous expression of Cx36 of neurons on the left 
hemisphere subjected to 30min MCAo in the ischemic region and the controlateral control 
hemisphere. We studied Cx36 in the lesion region defined by the cresyl violet staining and the 
anti-cleaved caspase 3 labelling, which is the region containing potentially viable but not 
functional brain tissue and where recovery as well as degeneration are equally possible(Figure 
6). 30min of focal cerebral ischemia markedly increases the specific punctate Cx36 
immunolabelling in the ischemic region compared to the same region on the controlateral, 
non-ischemic hemisphere. 
A       B            
      
Figure 5) Anti-cleaved caspase 3 immunofluorescence: A: Cresyl violet staining, square indicates 
the region on the border of the lesion showed in B. B: a limit is traceable between the cleaved caspase 
3 labelling-positive and the adjacent non-apoptotic, only DAPI stained nuclei. Scale bar=50µm 
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3.4. GFAP and Connexin43 expression in focal cerebral ischemia  
In order to determine whether transient focal cerebral ischemia, rather than modulating Cx43 
protein abundance, changed the distribution and/or the expression of Cx43 to the border of the 
ischemic lesion, we performed a double immunofluorescence labelling using specific 
antibodies against Cx43 and GFAP known to specifically stain the differentiated astrocytes. 
To examine ischemia-induced alterations in Cx43 expression in astrocytes, consecutive slices 
from same mice brains used for cresyl violet staining and anti-cleaved caspase 3 studies were 
taken and concomitant anti-GFAP and anti-Cx43 immunofluorescence were performed. 
    
 
Figure 6) Cx36 immunolabelling is increased in the border of the ischemic hemisphere: 
representative immunofluorescence images comparing the punctate Cx36 labelling (appearing in 
green) between the control and ischemic hemisphere of three different mice brains. DAPI 
counterstaining appears blue. Scale bar=20µm   
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It has been suggested that astrocytic gap junctions could be important for the regulation of 
neuronal apoptosis and the inflammatory response after an ischemic insult on brain tissue 
(Nakase, Sohl et al. 2004). Previous work suggested that reactive astrocytes (GFAP positive 
cells) are predominantly located in the spared parenchyma bordering the ischemic zone 
(Benakis, Bonny et al. 2010). Concurrently, Connexin43 protein abundance remains 
unchanged after global cerebral ischemia (Oguro, Jover et al. 2001).  
We found that anti-GFAP immunofluorescence was decreased in the ischemic lesion, rather 
than augmented on the border (Figure 7). 
 
 
 
 
 
Cx43 expression, assessed by immunofluorescence, was not modulated by a 30min transient 
focal cerebral ischemia. We didn’t observe a difference between the ischemic and control 
brain tissue regarding Cx43 immunolabelling (Figure 8). Furthermore, there was no clear 
redistribution of Cx43 to the regions with more preponderant GFAP signal. The representative 
A        B 
      
 C        D 
    
Figure 7) GFAP immunolabelling in the cortex: A: anti-GFAP labelling B: DAPI staining shows 
nuclear morphological differences between the ischemic lesion and the adjacent parenchyma. 
Squares indicate the magnifications C and D (C lower square, D upper square). Scale bar=50µm 
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pictures in Figure 8 show that the specific Cx43 labelling is more prevalent in regions without 
anti-GFAP labelling. Cx43 was either strongly localized as on mouse 8 tissue slices, or 
detected as a rather diffuse punctate as shown on mouse 30 tissue. 
 
 
 
 
 
 
 
 
 
 
 
 
3.5. Transient focal cerebral ischemia induces no detectable modulation in Connexin36 
protein abundance in ischemic tissue 
To assess semi-quantitatively the effects of transient focal cerebral ischemia on Cx36 
expression, we performed Western blot analysis. The ischemic lesion was isolated from 
adjacent normal tissue and samples of whole cell protein were subjected to gel electrophoresis 
and incubated with specific antibodies against Cx36. As a positive control, we also examined 
Cx36 expression in the insulin-secreting INS-1 beta-cells which together with neurons 
exclusively express Cx36 (Martin, Tawadros et al. 2003). This preliminary work showed a 
slightly more intense signal in some of the control tissue samples (8, 10, and 11) in the 
Western blot done without concomitant tubulin labelling to assure equivalent protein loading 
         
Figure 8) Concomitant GFAP and Cx43 immunolabelling: 
Comparison between the ischemic and non-ischemic hemisphere. GFAP labelling appears in 
red, Cx43 labelling appears in green, DAPI counterstaining appears in blue. Scale bar=20µm 
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in all pits (Figure 9A). The INS-1 protein sample showed an intense, specific signal for the 
antibody against Cx36. 
In Figure 9B, although there was specific anti-Cx36 signal in the INS-1 protein sample at 
36kDa, the signal in the brain protein samples is positive at 28kDa as indicated by the protein 
molecular weight marker. Also, we didn’t observe a detectable difference in Cx36 expression 
between ischemic and control tissue. Anti-tubulin signal demonstrated that the amount of 
proteins loaded on the gel were similar between the samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
To assess quantitatively effects of transient focal cerebral ischemia on Cx43 expression, we 
performed Western blot analysis. The ischemic lesion was isolated from adjacent normal 
tissue and samples of whole cell protein were subjected to gel electrophoresis and incubated 
with specific antibodies against Cx43. As a negative control, we also examined Cx43 
expression in INS-1 beta-cells which do not express Cx43. 
            A 
           
 
            B 
 
 
Figure 9) Western blot Connexin36: 
Numbers 7, 8, 10, 11 indicate different mice brains, d: right hemisphere, control, g: left 
hemisphere, concentrated ischemic tissue. INS: beta cells used as positive control 
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There was no difference in Cx43 expression seen between the ischemic and control tissue. 
Anti-tubulin signal demonstrated that the amount of proteins loaded on the gel were similar 
between the samples (Figure 10). 
 
 
4. Discussion and Perspectives 
The present work was undertaken to examine the regulation of the gap junction protein 
Connexin36 in neurons in a mouse model of middle cerebral artery occlusion-induced 
transient focal cerebral ischemia. 
We observed a qualitative increase of Cx36 immunofluorescence signal in the penumbral 
region of the ischemic hemisphere compared to control tissue in 6 out of 19 different mice 
subjected to 30min of transient focal cerebral ischemia induced by MCAo.  
This observation is in accordance with results from a previous study (Oguro, Jover et al. 
2001) and compatible with a role for Cx36 in survival and/or apoptosis of penumbral neurons.  
In contrast to the study mentioned above which used 20min of global ischemia induced by 
bilateral occlusion of the arteria carotis communis, the present work used the MCAo mouse 
model for transient focal cerebral ischemia, creating a localized ischemic lesion with a 
surrounding penumbral region. This model enables the study of the ischemic penumbra while 
 
Figure 10) Western blot Connexin43: 
Numbers 7, 8, 10, 11 indicate different mice brains, d: right hemisphere, control, g: left 
hemisphere, concentrated ischemic tissue. INS: beta cells used as negative control. 
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being closer to the pathophysiological reality of a human cerebrovascular accident (85% of all 
cerebrovascular accidents are of thrombo-embolic nature, 25% in the territory of arteria 
cerebri media). It is unclear why the increase in Cx36 expression in the border of the 
penumbral region was observed in only 6 out of 19 mice. One possibility could be variations 
in the MCAo model between the mice as anatomical variations of collaterals in brain 
perfusion lead to differences in residual cerebral blood flow during MCAo or variable post-
surgical mouse activity/seizures leading to more or less oxygen demand of tissues. These 
explanations are in accordance with the observation that repeated immunofluorescence studies 
on different slices of the same mouse brain led to comparable results.  
On the other hand, personal experience and handling from mouse to microscope are obviously 
of importance. Working as a student with no antecedent laboratory training, errors might have 
occurred during manipulations leading to misinterpretation of the results. Finally, the punctate 
Cx36 signal on the microscope is weak compared to a nuclear DAPI counterstaining and the 
visualisation of the fluorescent positive signals as well as the interpretation of the observable 
data is not easy for an untrained person. 
The absence of a detectable modulation in Cx36 protein abundance in ischemic tissue 
assessed by Western blot analysis is in conflict with previous work (Oguro, Jover et al. 2001), 
who observed that 20min of global cerebral ischemia increased Cx36 protein abundance. An 
explanation for this could be the fact that, in contrast to the model of global cerebral ischemia, 
where a sample from any part of the brain can be used for Western blot analysis, we had to 
isolate the ischemic lesion tissue. Not only it is difficult to macroscopically determine the 
pathophysiological border of the lesion on cryosections of brain tissue, but also the isolation 
of the lesion with a surgical blade is not easily done. It is likely that  we “diluted” the 
ischemic lesion tissue with the adjacent normal tissue in a way that the relatively small 
increase of Cx36 protein abundance in the lesion is negligible compared to the overall Cx36 
protein abundance in the whole cell protein sample observed. 
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The main problem that we encountered during the Western blot analysis was related to the 
molecular weight of the Cx36 protein in brain tissue. Using INS-1E cells known to express 
Cx36 as a positive control, we observed a band at 36kDa in the control as expected, whereas  
the molecular size of the Cx36 immunodetected band in the brain extracts appeared at a size 
of 28kDa. It is possible that the specific band that we should observe at 36kDa was not 
detected in brain samples due to the lower expression levels of Cx36 in brain tissue (made of 
different types of cells which do not expressed Cx36) compared to INS-1E cells known to 
express high levels of Cx36 (Figure 9A). The use of brain samples from mice deleted for 
Cx36 (KO-Cx36), which are viable and lack behavioural or morphological abnormalities 
(Talhouk, Zeinieh et al. 2008) may be helpful to resolve this discrepancy.  
The application of the MCAo transient focal cerebral ischemia model KO-Cx36mice would 
be a valuable model for the evaluation and comparison of the lesion volume between wild-
type and transgenic mice. This may help to better understand the importance and role of Cx36 
mediated intercellular communication in the destiny of penumbral neurons. 
The Cx43 expressed in astrocytes has been shown to be involved in the pathology of neuronal 
disorders, including brain ischemia (Nakase, Sohl et al. 2004). As global cerebral ischemia 
did not alter Cx43 protein abundance (Oguro, Jover et al. 2001) and reactive astrocytes 
(GFAP positive cells) are predominantly located in the spared parenchyma bordering the 
ischemic zone (Benakis, Bonny et al. 2010), we studied whether transient focal cerebral 
ischemia, rather than modulating overall Cx43 protein abundance, changed the distribution of 
Cx43 in the border of the ischemic lesion, together with the GFAP positive cells. Even though 
it appeared difficult to assess the amount of anti-GFAP immunofluorescence signal on 
microscopic study, we found that the signal was diminished in the lesion, rather than 
increased around the lesion. Also, this was only possible to determine in brains with a 
corticostriatal lesion. Indeed, the corpus callosum, which surrounds the striatum and 
consequently a striatal ischemic lesion, is naturally rich in astrocytic GFAP (observed on the 
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control hemisphere). It was thus difficult to determine a modulation of the GFAP signal 
bordering the lesion. 
We performed co-immunolocalization studies of GFAP and Cx43 to visualize a possible 
modulation of GFAP in association with a regulation of Cx43 labelling. We didn’t find a 
global difference concerning Cx43 expression between ischemic and control tissue, which 
was also observed by Oguro et al. (Oguro, Jover et al. 2001). Furthermore, we didn’t observe 
a modulation of Cx43 expression in GFAP-rich regions. In Figure 10 though, it seems that the 
specific Cx43 labelling is more prevalent in regions without GFAP labelling. It may be 
possible that the relatively weak Cx43 signal is masked by the much more intense GFAP 
signal on positions were both signals overlap. 
Characterizing temporal, spatial and cellular differences in connexin expression is crucial to 
better understand the role of these different proteins in normal and pathophysiological 
conditions. The events taking place in an ischemic brain are complex and depend on different 
cell types and different types of intercellular communication. Both inflammation and hypoxia 
result in scenarios that add to the complexity of the issue (Talhouk, Zeinieh et al. 2008; 
Benakis, Bonny et al. 2010). 
The role of connexins in the pathology of diseases in the central nervous system is still 
ambiguous  and unravelling the function of gap junctions in the neural cell network, involving 
neurons, astrocytes and oligodendrocytes is of critical importance (Nakase and Naus 2004; 
Talhouk, Zeinieh et al. 2008).  
A better understanding of the role of gap junctions may contribute to the development of new 
therapeutic approaches to treat brain diseases, including cerebral ischemia.  
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